We view today's CE approval for XVIVO's heart technology very positively, removing one of the key regulatory overhangs in the case and paving the way for a broader commercial launch across Europe. We already include the European heart launch in our estimates and make no changes, but see the announcement as an important de-risking event.
LÄS MER
